Skip to main content
Back to AI Intelligence Briefing
RegulationAugust 17, 2026Source: Healthcare AI Insights

AI in Health: Regulatory and Policy Tracker — Q2 2026

This regulatory tracker reviews the global landscape for AI in health, emphasizing that the FDA has not yet authorized any large language model or generative AI systems as medical devices for diagnostic or treatment decision support. It also maps upcoming high‑risk AI system requirements that affect clinical AI tools, including deadlines tied to the EU AI Act and related health regulations.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.